SecBot SecBot
Insider Cluster (4 insiders) ·Filed Apr 9, 2026

BLTE

BELITE BIO, INC
BEARISH
Impact 7/10
Horizondays Processed6mo ago
Insider cluster: 4 insiders, $1.0M total
Actionable Insight ▼ Bearish

Coordinated selling by top executives, including C-suite, raises concerns about confidence in near-term prospects. Monitor upcoming earnings or pipeline updates for potential catalysts that may have prompted the timing. While the dollar amount is modest relative to market cap, the concentration among executives amplifies the negative signal.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
BLTE ▼ -14.99% at T+60d
SHORT call ✓ call won +14.99% · α vs SPY +25.77% · entry $181.17 → $154.02
Entry = T+0 close
Apr 8, 2026
via day close
T+1d
-4.64%
call +4.64% · α +4.58%
$172.76
settled 7mo ago
T+5d
-12.76%
call +12.76% · α +15.95%
$158.05
settled 6mo ago
T+20d
-13.78%
call +13.78% · α +21.34%
$156.21
settled 6mo ago
T+60d
-14.99%
call +14.99% · α +25.77%
$154.02
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Four insiders at Belite Bio, including the CEO, CFO, and Chief Scientific Officer, sold shares in a coordinated cluster totaling $1.04 million over an 8-day period. All transactions were open-market sales, with the majority occurring on April 9, 2026, at prices near $180 per share.

Key Financial Metrics

Direction
selling
Total Value
$1.0M
Insiders
4

Key Facts

  • CEO Lin Yu-Hsin sold 2,500 shares for $451,000
  • CFO Chuang Hao-Yuan sold 2,000 shares for $361,000
  • Director Chen Wan-Shan sold 1,100 shares for $198,000
  • CSO Nathan L. Mata sold 216 shares for $34,188 on April 16, following two prior small sales
  • All trades were open-market sales (code 'S'), totaling $1.04M in value

Financial Impact

$1.04 million in insider sales over 8 days, representing 0.016% of the company's $6.5B market cap

insider ownershipmarket sentimentshareholder dilution risk (none)

Risk Factors

  • Perceived lack of confidence from executive team
  • Potential for negative market reaction despite small absolute size
  • Possible anticipation of adverse clinical or regulatory news

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BLTE-1776716163174
11 reports for BLTE
Performance horizon
71% Hit rate @ T+20 5 of 7 directional calls Went positive at some point 6 of 7 best @ T+60▲ +26.98%Jun 12, 2026
Filters
Rows
Reports for BLTE — sortable, filterable
TypeNow
Oct 19, 2026
7d ago
6-K
NEUTRAL ★ 4/10
$147.34awaiting T+20—$147.33 (−0.01%)
Sep 9, 2026
6w ago
Insider Cluster
BEARISH ★ 6/10
$175.07 $152.52▲ +12.88%▲ +15.01%$147.33 (+15.85%)
Aug 12, 2026
10w ago
6-K
BULLISH ★ 7/10
$166.28 $173.79▲ +4.52%▲ +6.26%$147.33 (−11.40%)
Aug 12, 2026
10w ago
Press Release
BULLISH ★ 7/10
$166.28 $173.79▲ +4.52%▲ +6.26%$147.33 (−11.40%)
Jun 12, 2026
19w ago
6-K
BULLISH ★ 6/10
$144.24 $147.03▲ +1.93%▲ +2.68%$147.33 (+2.14%)
May 20, 2026
22w ago
Press Release
MIXED ★ 6/10
$143.36 $146.12▲ +1.93%▲ +1.18%$147.33 (+2.77%)
Apr 21, 2026
26w ago
6-K
BULLISH ★ 8/10
$167.42 $139.70▼ −16.56%▼ −19.72%$147.33 (−12.00%)
Apr 21, 2026
26w ago
Press Release
NEUTRAL ★ 5/10
$167.42 $139.70▼ −16.56%▼ −19.72%$147.33 (−12.00%)
Apr 9, 2026
28w ago
Insider Cluster
BEARISH ★ 7/10
$181.17 $156.21▲ +13.78%▲ +21.34%$147.33 (+18.68%)
Apr 9, 2026
28w ago
Insider Cluster
BEARISH ★ 6/10
$181.17 $156.21▲ +13.78%▲ +21.34%$147.33 (+18.68%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 20, 2026